Quan 泽熙系股票 泽熙系股票te 泽熙系股票rix Corp公司介绍
| 证券代码： |
QTRX |
上市板： |
主板 |
| 证券名称： |
Quanterix Corp |
上市场所： |
纳斯达克交易所 |
| 证券类型： |
普通股 |
发行方式： |
公开发售 |
| 首发上市日： |
2017/12/07 |
首发价格(元)： |
- |
| 首发数量(股)： |
- |
首发募资总额(USD/元)： |
- |
Quanterix Corp基本资料
| 公司名称： |
Quanterix Corporation |
注册地址： |
美国特拉华州 |
| 证券名称： |
Quanterix Corp |
上市场所： |
纳斯达克交易所 |
| 办公地址： |
113 泽熙系股票hartwell Avenue, Lexington, Massachusetts, USA |
| 董事会主席： |
- |
成立日期： |
2007/04/01 |
| 公司属地： |
United States 美国 |
电话： |
+1 (617) 301-9400 |
| 公司网址： |
www.quanterix.com |
| 公司介绍： |
Quanterix Corporation is a life sciences company that has developed a next generation, ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its platform enables customers to reliably detect protein biomarkers in extremely low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies. These capabilities provide its customers with insight into the role of protein biomarkers in human health that has not been possible with other existing technologies and enable researchers to better characterize the continuum between health and disease. The company believes this greater insight provided by its platform, in research applications today and in diagnostic and precision health settings in the future, will enable the development of novel therapies and diagnostics and facilitate a paradigm shift in healthcare from an emphasis on treatment to a focus on earlier detection, monitoring, prognosis and, ultimately, prevention. In addition to enabling new applications and insights in protein analysis, it is also developing its Simoa technology to detect nucleic acids in biological samples. |
本文来自投稿，不代表本人立场，如若转载，请注明出处：http://www.smctrader.com/shangshigongsi/133873.html
本站所有数据资料均来自第三方，仅作为用户获取信息，不构成投资建议，SMC股票学习网不为内容负责。
标签：
QTRX
QTRX股票
Quanterix Corp股票代码
QTRX股票行情
Quanterix Corp公司概况
QTRX基金净值
QTRX股吧
Quanterix Corp公司档案